Scarica l'app Stockscreener
1.96
7.55%
-0.16
Dopo l'orario di chiusura:
1.96
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$2.12
Aprire:
$2.04
Volume 24 ore:
56,851
Relative Volume:
0.09
Capitalizzazione di mercato:
$3.82M
Reddito:
-
Utile/perdita netta:
$-19.09M
Rapporto P/E:
-0.9032
EPS:
-2.17
Flusso di cassa netto:
$-16.92M
1 W Prestazione:
-12.50%
1M Prestazione:
-63.75%
6M Prestazione:
-63.71%
1 anno Prestazione:
-83.99%
Intervallo 1D:
$1.80
$2.1486
Intervallo di 1 settimana:
$1.80
$2.44
Portata 52W:
$1.80
$21.96
Organovo Holdings Inc Stock (ONVO) Company Profile
Nome
Organovo Holdings Inc
Settore
Industria
Telefono
858-224-1000
Indirizzo
11555 SORRENTO VALLEY ROAD, SAN DIEGO, CA
Confronta ONVO con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
ONVO
Organovo Holdings Inc
|
1.96 | 3.82M | 0 | -19.09M | -16.92M | -2.17 |
|
VRTX
Vertex Pharmaceuticals Inc
|
474.56 | 121.88B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
572.78 | 62.69B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
550.00 | 33.54B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
232.95 | 30.15B | 2.25B | -278.16M | -42.59M | -2.17 |
|
ONC
Beigene Ltd Adr
|
220.54 | 25.69B | 3.81B | -644.79M | -669.77M | -6.24 |
Organovo Holdings Inc Stock (ONVO) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2018-12-13 | Iniziato | H.C. Wainwright | Buy |
| 2017-11-10 | Downgrade | Raymond James | Outperform → Mkt Perform |
| 2017-01-25 | Iniziato | Raymond James | Outperform |
| 2015-08-11 | Downgrade | Cantor Fitzgerald | Buy → Hold |
| 2015-06-29 | Iniziato | Jefferies | Buy |
| 2015-06-29 | Iniziato | Piper Jaffray | Overweight |
Mostra tutto
Organovo Holdings Inc Borsa (ONVO) Ultime notizie
Organovo (NASDAQ:ONVO) Earns Sell Rating from Analysts at StockNews.com - Defense World
Organ On A Chip Market Generated Opportunities, Future Scope - openPR.com
Organovo (ONVO) Anticipates $5M Cash Influx as Nasdaq Compliance Continues - GuruFocus
Organovo reports $11.3M cash balance in FY24 - MSN
Organovo Provides Update on Cash and Nasdaq Continued Listing Requirements - The Manila Times
Organovo Holdings Expects to Meet Nasdaq Listing Requirements - TipRanks
Organovo expects to maintain Nasdaq listing with stable stock price By Investing.com - Investing.com Australia
Organovo expects to maintain Nasdaq listing with stable stock price - Investing.com
Organovo's Financial Update: $11.3M Cash Reserve Plus $55M Potential Milestone Payments - Stock Titan
Organovo stock plunges to 52-week low of $2.13 amid steep decline - Investing.com Canada
ONVO Stock Quote Price and Forecast - CNN
Organovo Holdings (ONVO) Sells FXR Program to Lilly (LLY), Secures Financial Future - GuruFocus
Organovo sells FXR Program, anticipates reduced costs By Investing.com - Investing.com South Africa
Organovo gets upfront payments following sale of its FXR Program to Lilly - Seeking Alpha
Organovo Provides Business Update - Quantisnow
Organovo sells FXR Program, anticipates reduced costs - Investing.com India
Organovo Holdings Completes Sale of FXR Program to Lilly - TipRanks
StockNews.com Initiates Coverage on Organovo (NASDAQ:ONVO) - Defense World
Organovo Holdings Inc Receives Upfront Payments From FXR Program Sale To Lilly - MarketScreener
Latest: Organovo Secures Future Through 2026 Following Major Lilly Partnership Deal - Stock Titan
Organovo Holdings Completes FXR Program Sale to Eli Lilly - TipRanks
Organovo Announces Close Of Sale Of FXR Program To Eli Lilly And Company - Marketscreener.com
Eli Lilly Wraps Up Acquisition of Organovo's FXR Program - Marketscreener.com
Organovo Completes Sale of FXR Program to Eli Lilly - Marketscreener.com
Organovo Announces Close of the Sale of FXR Program to Eli Lilly and Company - The Manila Times
Organovo Announces Close Of The Sale Of FXR Program To Eli Lilly And Company - menafn
Major Deal: Eli Lilly Acquires Organovo's FXR Program in Strategic Asset Purchase - Stock Titan
Healthcare 3D Printing Market Demand, Growth and Future Scope - openPR.com
3D Printing in Regenerative Medicine Market Generated - openPR.com
Organovo stock hits 52-week high at $3.67 amid market fluctuations - Investing.com Australia
Organovo announces 1-for-12 reverse stock split - Investing.com India
Organovo announces 1-for-12 reverse stock split By Investing.com - Investing.com Australia
Organovo announces reverse stock split; shares fall - MSN
Organovo Announces 1-for-12 Reverse Stock Split To Maintain Nasdaq Compliance - Nasdaq
Dow Surges Over 200 Points; US Crude Oil Inventories Increase More than Expected - Benzinga
Nasdaq Gains Over 1%; Williams-Sonoma Shares Plunge After Q4 Results - Benzinga
Organovo Announces 1-for-12 Reverse Stock Split - TipRanks
Organovo Announces Reverse Stock Split - The Manila Times
Organovo Holdings, Inc. Announces 1-for-12 Reverse Stock Split Effective March 20, 2025 - Nasdaq
Organovo's Major Stock Restructuring: 1:12 Reverse Split Coming March 20 - StockTitan
Organovo (NASDAQ:ONVO) Now Covered by StockNews.com - Defense World
Matinas BioPharma Appoints Seasoned Biotech Leaders to Board of Directors - The Manila Times
Matinas BioPharma Lands Organovo Chairman, Pharma Veteran in Strategic Board Revamp - StockTitan
Organovo Holdings Inc Azioni (ONVO) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.48%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):